Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1998 May;53(5):357–362. doi: 10.1136/thx.53.5.357

Neurokinin A is the predominant tachykinin in human bronchoalveolar lavage fluid in normal and asthmatic subjects

L Heaney 1, L Cross 1, L McGarvey 1, K Buchanan 1, M Ennis 1, C Shaw 1
PMCID: PMC1745230  PMID: 9708226

Abstract

BACKGROUND—Multiple sensory neuropeptides are present in human airways and may contribute to diseases such as asthma. This study quantified and characterised substance P (SP), neurokinin A (NKA), and calcitonin gene related peptide (CGRP) immunoreactivity in bronchoalveolar lavage fluid in asthmatic and normal subjects.
METHODS—Using specific radioimmunoassay (RIA), SP, NKA and CGRP were measured in bronchoalveolar lavage fluid from asthmatic subjects (n = 5), normal subjects (n = 5), atopic non-asthmatic subjects (n = 6), and asthmatic subjects four hours after allergen challenge (n = 12). Peptide immunoreactivity was characterised using high performance liquid chromatography (HPLC) and RIA.
RESULTS—No SP or CGRP immunoreactivity was detected in any of the fractions from samples after extraction, HPLC, and RIA. Non-specific binding resulted in spurious SP immunoreactivity being detected in bronchoalveolar lavage fluid when no extraction process was employed. NKA was detected in significant amounts in asthmatic (median 550, range 425-625 pg/ml) and normal subjects (median 725, range 350-1425 pg/ml). The level of NKA was significantly higher in the asthmatic subjects after allergen challenge (median 750, range 350-1250 pg/ml) than in unchallenged asthmatic subjects (median 600, range 425-600 pg/ml, p<0.01).
CONCLUSIONS—Extraction and characterisation of peptides from bronchoalveolar lavage fluid must be performed to ensure that the measured immunoreactivity represents target peptide. NKA is present in bronchoalveolar lavage fluid in high concentrations and is the predominant tachykinin. The concentrations of NKA are similar in normal subjects and subjects with mild asthma.



Full Text

The Full Text of this article is available as a PDF (123.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Advenier C., Naline E., Toty L., Bakdach H., Emonds-Alt X., Vilain P., Brelière J. C., Le Fur G. Effects on the isolated human bronchus of SR 48968, a potent and selective nonpeptide antagonist of the neurokinin A (NK2) receptors. Am Rev Respir Dis. 1992 Nov;146(5 Pt 1):1177–1181. doi: 10.1164/ajrccm/146.5_Pt_1.1177. [DOI] [PubMed] [Google Scholar]
  2. Bakhle Y. S., Bell C. Neurokinin A and substance P vary independently in different regions of rat sensory neurons. Neuropeptides. 1995 Apr;28(4):237–241. doi: 10.1016/0143-4179(95)90027-6. [DOI] [PubMed] [Google Scholar]
  3. Ben-Jebria A., Marthan R., Rossetti M., Savineau J. P. Effect of passive sensitization on the mechanical activity of human isolated bronchial smooth muscle induced by substance P, neurokinin A and VIP. Br J Pharmacol. 1993 May;109(1):131–136. doi: 10.1111/j.1476-5381.1993.tb13542.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cockcroft D. W., Killian D. N., Mellon J. J., Hargreave F. E. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy. 1977 May;7(3):235–243. doi: 10.1111/j.1365-2222.1977.tb01448.x. [DOI] [PubMed] [Google Scholar]
  5. Crimi N., Palermo F., Oliveri R., Palermo B., Polosa R., Mistretta A. Protection of nedocromil sodium on bronchoconstriction induced by inhaled neurokinin A (NKA) in asthmatic patients. Clin Exp Allergy. 1992 Jan;22(1):75–81. doi: 10.1111/j.1365-2222.1992.tb00117.x. [DOI] [PubMed] [Google Scholar]
  6. Crimi N., Palermo F., Oliveri R., Palermo B., Vancheri C., Polosa R., Mistretta A. Effect of nedocromil on bronchospasm induced by inhalation of substance P in asthmatic subjects. Clin Allergy. 1988 Jul;18(4):375–382. doi: 10.1111/j.1365-2222.1988.tb02885.x. [DOI] [PubMed] [Google Scholar]
  7. Fujishima H., Takeyama M., Takeuchi T., Saito I., Tsubota K. Elevated levels of substance P in tears of patients with allergic conjunctivitis and vernal keratoconjunctivitis. Clin Exp Allergy. 1997 Apr;27(4):372–378. [PubMed] [Google Scholar]
  8. Hazbun M. E., Hamilton R., Holian A., Eschenbacher W. L. Ozone-induced increases in substance P and 8-epi-prostaglandin F2 alpha in the airways of human subjects. Am J Respir Cell Mol Biol. 1993 Nov;9(5):568–572. doi: 10.1165/ajrcmb/9.5.568. [DOI] [PubMed] [Google Scholar]
  9. Joos G. F., Pauwels R. A. The bronchoconstrictor effect of sensory neuropeptides in man. Ann N Y Acad Sci. 1991;629:371–382. doi: 10.1111/j.1749-6632.1991.tb37990.x. [DOI] [PubMed] [Google Scholar]
  10. Joos G., Pauwels R., van der Straeten M. Effect of inhaled substance P and neurokinin A on the airways of normal and asthmatic subjects. Thorax. 1987 Oct;42(10):779–783. doi: 10.1136/thx.42.10.779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kage R., McGregor G. P., Thim L., Conlon J. M. Neuropeptide-gamma: a peptide isolated from rabbit intestine that is derived from gamma-preprotachykinin. J Neurochem. 1988 May;50(5):1412–1417. doi: 10.1111/j.1471-4159.1988.tb03024.x. [DOI] [PubMed] [Google Scholar]
  12. Kawaguchi Y., Hoshimaru M., Nawa H., Nakanishi S. Sequence analysis of cloned cDNA for rat substance P precursor: existence of a third substance P precursor. Biochem Biophys Res Commun. 1986 Sep 30;139(3):1040–1046. doi: 10.1016/s0006-291x(86)80282-0. [DOI] [PubMed] [Google Scholar]
  13. Martling C. R. Sensory nerves containing tachykinins and CGRP in the lower airways. Functional implications for bronchoconstriction, vasodilatation and protein extravasation. Acta Physiol Scand Suppl. 1987;563:1–57. [PubMed] [Google Scholar]
  14. Nawa H., Kotani H., Nakanishi S. Tissue-specific generation of two preprotachykinin mRNAs from one gene by alternative RNA splicing. Nature. 1984 Dec 20;312(5996):729–734. doi: 10.1038/312729a0. [DOI] [PubMed] [Google Scholar]
  15. Nieber K., Baumgarten C. R., Rathsack R., Furkert J., Oehme P., Kunkel G. Substance P and beta-endorphin-like immunoreactivity in lavage fluids of subjects with and without allergic asthma. J Allergy Clin Immunol. 1992 Oct;90(4 Pt 1):646–652. doi: 10.1016/0091-6749(92)90138-r. [DOI] [PubMed] [Google Scholar]
  16. Nieber K., Baumgarten C., Rathsack R., Furkert J., Laake E., Müller S., Kunkel G. Effect of azelastine on substance P content in bronchoalveolar and nasal lavage fluids of patients with allergic asthma. Clin Exp Allergy. 1993 Jan;23(1):69–71. doi: 10.1111/j.1365-2222.1993.tb02486.x. [DOI] [PubMed] [Google Scholar]
  17. Shaw C., Foy W. L., Johnston C. F., Buchanan K. D. Identification and characterization of multiple tachykinin immunoreactivities in bovine retina: evidence for the presence of a putative oxidative inactivation system for substance P. J Neurochem. 1989 Nov;53(5):1547–1554. doi: 10.1111/j.1471-4159.1989.tb08551.x. [DOI] [PubMed] [Google Scholar]
  18. Simon C., Portalier P., Chamoin M. C., Ternaux J. P. Substance P like-immunoreactivity release from enterochromaffin cells of rat caecum mucosa. Inhibition by serotonin and calcium-free medium. Neurochem Int. 1992 Jun;20(4):529–536. doi: 10.1016/0197-0186(92)90032-m. [DOI] [PubMed] [Google Scholar]
  19. Springall D. R., Polak J. M. Localization of peptides in the lung. Ann N Y Acad Sci. 1991;629:288–304. doi: 10.1111/j.1749-6632.1991.tb37984.x. [DOI] [PubMed] [Google Scholar]
  20. Takeyama M., Nagai S., Mori K., Ikawa K., Satake N., Izumi T. Substance P-like immunoreactive substance in bronchoalveolar lavage fluids from patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 1996 Mar;13(1):33–37. doi: 10.1007/BF00383966. [DOI] [PubMed] [Google Scholar]
  21. Tatemoto K., Lundberg J. M., Jörnvall H., Mutt V. Neuropeptide K: isolation, structure and biological activities of a novel brain tachykinin. Biochem Biophys Res Commun. 1985 Apr 30;128(2):947–953. doi: 10.1016/0006-291x(85)90138-x. [DOI] [PubMed] [Google Scholar]
  22. Wershil B. K., Turck C. W., Sreedharan S. P., Yang J., An S., Galli S. J., Goetzl E. J. Variants of vasoactive intestinal peptide in mouse mast cells and rat basophilic leukemia cells. Cell Immunol. 1993 Oct 15;151(2):369–378. doi: 10.1006/cimm.1993.1246. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES